COVID-19, HIV vaccine and cure news, and long-acting HIV treatment and prevention topped the news again this year. By Liz Highleyman and Ian Anderson | POZ via PHARMATIVE In the second year of the pan...
By Sandra Lopez-Leon et al. | Nature via PHARMATIVE Abstract COVID-19 can involve persistence, sequelae, and other medical complications that last weeks to months after initial recovery. This systemat...
By Kathy Katella | Yale Medicine via PHARMATIVE Yale Medicine doctors answer common questions about Merck’s new COVID-19 treatment. Over the past year, discussions—sometimes heated ones—about ending t...
In December of 2020, Moderna and Pfizer-BioNTech each successfully developed two COVID-19 messenger RNA vaccines with 95% efficacy in the prevention of severe acute respiratory syndrome coronavirus 2 ...
By James Partyka | PHARMATIVE Dr. James Partyka provides a review of new emerging clinical data of two medcines demonstrating efficacy in the treatment of COVID-19 Disease. See video below.
By Maggie Baska | Pink News vis PHARMATIVE A unique, one-time treatment for HIV has been given the green light to begin human trials by the US Food and Drug Administration (FDA). Excision BioTherapeut...
By Food and Drug Administration via POZ & PHARMATIVE Third dose OK’d for people over 65, those at risk for severe COVID-19 and those at high risk of exposure to the coronavirus. [On September 22],...
By Paul Blest | WebMD via Vice and PrideNation.com A TikToker who spent her final conscious days begging people to get vaccinated has passed away after being hospitalized due to COVID-19, according to...
U.S. health officials now recommend another vaccine dose for all Americans. Here’s what that means for you. By Catherine Pearson | HuffPost via PHARMATIVE.com For months, vaccine manufacturers a...